Navigation Links
DelMar Pharmaceuticals To Present At The 15th Annual Rodman & Renshaw Global Investment Conference
Date:9/3/2013

VANCOUVER, British Columbia and MENLO PARK, Calif., Sept. 3, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc., (OTCQB: DMPI), developer of advanced cancer therapeutics, will be featured as a presenting company at the 15th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC.  The presentation will take place Monday, September 9th at 3:15 p.m. EDT in Room 7.02 at the Millennium Broadway Hotel in New York City.  The presentation will be webcast live at http://wsw.com/webcast/rrshq23/DMPI and available for 90 days.

Jeffrey Bacha, president and CEO of DelMar, will provide an overview of DelMar's timely progress in developing important, new chemotherapies for patients who have little to no therapeutic options. 

DelMar's lead drug, VAL-083, is being developed to treat glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer. VAL-083 is approved in China to treat chronic myelogenous leukemia and lung cancer and has received orphan drug designation in Europe and in the United States.

Developing Essential New Treatments for Aggressive Brain Cancers

Fifty percent of patients with GBM will fail today's approved therapies, Temodar® and Avastin®.  Tumor resistance to Temodar is well documented and known to be caused by the MGMT enzyme. Studies by the National Cancer Institute and DelMar have shown that VAL-083 acts through a unique mechanism unaffected by MGMT and has activity against a range of cancers. 

DelMar is conducting a Phase I/II clinical trial to assess the safety and efficacy of VAL-083 as
'/>"/>

SOURCE DelMar Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. DelMar Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
2. DelMar Pharmaceuticals Presents Additional Clinical Data from Ongoing Brain Cancer Study at ASCO
3. DelMar Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com June 6th
4. DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
5. DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
6. DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083
7. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
8. DelMar Pharma Named to Rocket Builders 2013"Ready to Rocket" List
9. DelMar Pharmaceuticals to Present at the 25th Annual ROTH Capital Partners Growth Stock Conference
10. DelMar Pharmaceuticals Announces Completion Of $10.5 Million Oversubscribed Offering And Appointment Of Investor Relations Consultant
11. DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... FRANCISCO , July 2, 2015  The Green ... ), the world,s first HIPAA compliant mobile app that ... of farm-to-table fresh medical marijuana, announced today that their ... Unlike Eaze, Meadow and more than half a ... the last year, Loud Cannabis is unique in that ...
(Date:7/2/2015)... , July 2, 2015 Pharma ... stake in ZAO "Biocom" in Russia ... into the Russian pharmaceutical market which recorded RUB 765 billion ... pharmaceutical markets in the world in 2014 (IMS Health). For ... and expected to continue with this trend, projecting ...
(Date:7/2/2015)... CAMBRIDGE, Mass. , and DURHAM, N.C. ... Sciences , Inc. today announced its acquisition of assets ... Inc. (NYSE: PFE ) that had previously been ... Inc.  XRPro Sciences also acquired all of Pfizer,s rights ... re-launching the Icagen brand and will provide comprehensive services ...
Breaking Medicine Technology:New Cannabis Delivery App Gets Product to Patient in Under 7 Minutes 2Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4
... July 22 Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) announced ... July 29, 2010 , before the U.S. financial markets open. , ... Anadys will hold a conference call and webcast on ... to discuss its second quarter 2010 financial results and to provide an ...
... Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today that the Company will ... Wednesday, July 28, 2010 .  Neurocrine will then host a  live conference ... Thursday morning, July 29, 2010 at 8:30 a.m. Eastern Time ... , , ...
Cached Medicine Technology:Anadys Pharmaceuticals to Report Second Quarter 2010 Financial Results 2Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2010 Financial Results 2
(Date:7/5/2015)... , ... July 05, 2015 , ... Women’s Excellence ... college) at their Lake Orion location. The special consists of 2 months of unlimited ... Wellness, powered by Movestrong is located at 1410 South Lapeer Road in Lake Orion. ...
(Date:7/4/2015)... ... July 05, 2015 , ... Dating a real millionaire online ... best online millionaire dating service and strives to remove the worries from meeting partners. ... millionaire dating app of 2015 and readers have responded with excitement. ...
(Date:7/4/2015)... NY (PRWEB) , ... July 04, 2015 , ... Chronic ... 15% of chronic pain sufferers have pain located in the neck. Another 19% suffer ... the neck. Chiropractic literature suggests that 45% of American workers must deal ...
(Date:7/4/2015)... IRVINE, California (PRWEB) , ... July 04, 2015 ... ... has earned the solar industry’s leading recognition of technical sales expertise from the ... Certified PV Technical Sales ProfessionalTM. NABCEP is the most highly respected and well ...
(Date:7/3/2015)... ... July 03, 2015 , ... Brendon Burchard's new ... buzz of media attention. In an effort to spread the news, a comprehensive ... "These days many people are feeling overwhelmed by stress and fatigue," reports Hendricks. ...
Breaking Medicine News(10 mins):Health News:MillionaireMatchapp.com Publishes the Best Millionaire Dating App and Official Dating Site Reviews 2015 2Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3
... The World Health Assembly has given a powerful endorsement ... The strategy brings together crucial elements to reduce childhood ... reduce the 1.4 million adolescent deaths each year. ,Last ... was double the total number of adult deaths from ...
... Recent findings from the University of Hong Kong and,the Shenzhen ... virus from,animals. The findings are observed form a study conducted ... five out of the ten were found to have SARS ... them reported to be sick, thus suggesting that the workers ...
... its border with hard-hit China. ,The first confirmed case of ... Amur river, which forms the frontier with China, came as ... country could contain the disease.,Hu told students in Moscow, at ... strict measures to stop the spread of the deadly virus ...
... people over age 85 have Alzheimer’s disease. Now, researchers ... some postmenopausal women to develop dementia, which is a ... from Wake Forest University studied more than 4,500 postmenopausal ... Initiative. The WHI came to an early end last ...
... 2,000 people possibly exposed to the illness have been ... said Dr. Colin D'Cunha, Ontario's chief medical officer of ... since the outbreak could not control dozens of possible ... the WHO put Canada`s largest city back on its ...
... of a new form of deadly pneumonia is on the ... virus was first detected in South China Asia and is ... World Health Organization the follwing cases of SARS that have ... May 23:// , ,Total number of probable cases: 8,046 , ...
Cached Medicine News:Health News:Hope for 11 million children facing death from illnesses 2Health News:WHO Says Toronto Going Back on SARS-Affected List 2
... Maximum, Maximum Xtra, and Maximum ACT ... standard and specialty hemostasis introducers in ... the premier hemostasis introducers for use ... including angiography, angioplasty, stenting, atherectomy, temporary ...
... hemostasis introducers provide outstanding insertion ... dilator-to-sheath transitions, high kink resistance ... dual layer sheath cannula provides ... works with an extra strong ...
Bx VELOCITY Coronary Stent with HEPACOAT...
A steerable diagnostic catheter with optimal maneuverability...
Medicine Products: